Pharma Journalist 8769 posts 0 comments

NVIDIA and Eli Lilly and Company have announced the creation of a first-of-its-kind AI co-innovation lab designed to apply artificial intelligence to some of the most persistent…
Read More...

Atara Biotherapeutics has received a setback in its efforts to bring EBVALLO™ (tabelecleucel) to patients with Epstein-Barr virus–positive post-transplant lymphoproliferative disease…
Read More...

AbbVie has announced a voluntary agreement with the Trump administration aimed at expanding access and affordability of medicines for Americans while reinforcing the company’s long-term…
Read More...

AbbVie and RemeGen have entered into an exclusive global licensing agreement aimed at advancing RC148, a novel investigational bispecific antibody targeting both Programmed Cell Death-1…
Read More...

AbbVie and West Pharmaceutical Services have announced a definitive agreement under which AbbVie will acquire a device manufacturing facility and associated intellectual property from…
Read More...

Fortress Biotech, Inc. and its majority-owned subsidiary Cyprium Therapeutics have received a major regulatory milestone with the U.S. Food and Drug Administration’s approval of ZYCUBO®…
Read More...

BD (Becton, Dickinson and Company), a global leader in medical technology, has announced a $110 million investment to expand its production of prefillable syringes in the United States,…
Read More...

Solid Biosciences Inc., a life sciences company focused on developing precision genetic medicines for neuromuscular and cardiac diseases, has reached two important milestones in the…
Read More...

Synaffix B.V., a Lonza company, and Sidewinder Therapeutics have entered into a multi-target licensing agreement aimed at developing first-in-class bispecific antibody-drug conjugate…
Read More...

Alessa Therapeutics has received Fast Track designation from the U.S. Food and Drug Administration for Enolen®, its lead investigational therapy for the treatment of low- to…
Read More...